Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs11364692 | chr9:138779668 | CA/C | 0.000178 | 485 | 31.33 | 31.27 | 17.15 | KM Plot |
PRAD | rs11374166 | chr15:68078177 | C/CT | 0.000167 | 490 | 33.37 | 28.05 | 26.02 | KM Plot |
PRAD | rs113749311 | chr4:187811563 | T/G | 2.05E-6 | 483 | 31.23 | 28.3 | 26.8 | KM Plot |
PRAD | rs113816941 | chr2:178801661 | AT/A | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs113826521 | chr7:135167999 | T/C | 1.88E-9 | 492 | 30.53 | 32.63 | 3.03 | KM Plot |
PRAD | rs113836270 | chr6:168106966 | G/A | 3.54E-8 | 491 | 31.87 | 25.65 | 21.97 | KM Plot |
PRAD | rs113857308 | chr6:8520906 | G/T | 1.11E-7 | 491 | 30.73 | 35.93 | 20.93 | KM Plot |
PRAD | rs113921485 | chr3:112503023 | G/A | 2.15E-7 | 494 | 30.78 | 33.72 | 17.77 | KM Plot |
PRAD | rs113962908 | chr3:184190483 | G/A | 0.000172 | 475 | 32.27 | 28.23 | 30.02 | KM Plot |
PRAD | rs113972811 | chr4:5720407 | G/A | 0.000163 | 489 | 30.8 | 29.17 | 38.33 | KM Plot |
PRAD | rs113990079 | chr6:43389045 | G/A | 5.23E-12 | 482 | 31.25 | 29.97 | 44.3 | KM Plot |
PRAD | rs113995269 | chr4:187812723 | C/T | 2.06E-6 | 482 | 31.13 | 28.75 | 26.8 | KM Plot |
PRAD | rs114037201 | chr2:107439448 | G/A | 0.000115 | 492 | 30.87 | 30.7 | 32.63 | KM Plot |
PRAD | rs11418668 | chr8:143449824 | T/TG | 0.000115 | 487 | 30.63 | 31.02 | 31.87 | KM Plot |
PRAD | rs114356654 | chr4:187811298 | C/T | 2.06E-6 | 483 | 31.13 | 28.57 | 26.8 | KM Plot |